speb/financial-data huggingface dataset:
Financial ratios for 9258.T — annual report dated 2023-09-30
Total revenue: 16258309.896879604
Gross profit: 10520148.654077943
Operating income: 1489306.2809695995
Net income: 990364.2694522566
Capital expenditures: 1854.8279094683273
Operating cash flow: 1622103.9239319672
Depreciation & amortization: 552310.1647247891
Net tangible assets: 13067008.169278156
Owner earnings: 1540819.6062675773
Return on net tangible assets (%): 11.79167860237662
Capex to operating income (%): 0.12454307976602087
Buffett classification: The Great
Stock price: 2.6784518548279093
P/E ratio: 18.018158092237375
Shares outstanding: 6662259
Book value: 15415247.08718361
P/B ratio: 1.1575902659860744
Market cap (USD): 17844539.975893933
Debt to equity: 0.006521834505951705
Current ratio: 4.818635589544377
Quick ratio: 4.818635589544377
Effective tax rate (%): 33.06556724172263
Interest coverage ratio: 648.4344023323615
COGS to revenue (%): 35.29371305625663
Free cash flow (dilution-adjusted): 374507.83447167533
Buyback yield (%): 0
Retained earnings: 5247823.757867952
Receivables turnover: 16.28797595728124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.640237316287061
FCF margin (%): 2.303485644246166
Revenue growth (%): 7.6122080785341915
Rule of 40 score: 9.915693722780357
Financial ratios for 9258.T — annual report dated 2024-09-30
Total revenue: 19090040.621935844
Gross profit: 10683835.271046365
Operating income: -32721.669701638886
Net income: -65464.35074940468
Capital expenditures: 273322.59420086845
Operating cash flow: 906352.4303123687
Depreciation & amortization: 830011.2060512677
Net tangible assets: 13183800.252136154
Owner earnings: 491224.2611009946
Buffett classification: The Gruesome
Stock price: 2.7034598683288977
Shares outstanding: 6662259
Book value: 16096316.010645747
P/B ratio: 1.1189609987155344
Market cap (USD): 18011149.838913012
Debt to equity: 0.0021834175139846634
Current ratio: 3.654105304008618
Quick ratio: 3.654105304008618
Interest coverage ratio: -13.904761904761905
COGS to revenue (%): 44.03447071478782
Free cash flow (dilution-adjusted): -612971.0043423448
Buyback yield (%): 0.0006999446336795312
Retained earnings: 5423462.669841714
Receivables turnover: 10.685321813035603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.20328661193186243
FCF margin (%): -3.2109465688511767
Revenue growth (%): 17.41712849008816
Rule of 40 score: 14.206181921236983
Financial ratios for 9258.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 12875671.701644165
Buffett classification: The Gruesome
Stock price: 2.633337789065633
Shares outstanding: 6662259
Book value: 15495234.594305573
P/B ratio: 1.1322176685011238
Market cap (USD): 17543978.385242615
Debt to equity: 0
Current ratio: 3.2924890134181224
Quick ratio: 3.2924890134181224
Buyback yield (%): 0
Retained earnings: 5160907.632669429
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9258.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 11206776.581426648
Buffett classification: The Gruesome
Stock price: 2.705248990578735
Shares outstanding: 6662259
Book value: 14919239.569313597
P/B ratio: 1.2080420956437057
Market cap (USD): 18023069.434724092
Debt to equity: 0.1290934276470129
Current ratio: 2.7526141826923074
Quick ratio: 2.7496670673076924
Buyback yield (%): 0
Retained earnings: 4513977.119784657
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9258.T — annual report dated 2025-09-30
Total revenue: 21392806.191117093
Gross profit: 12046473.755047107
Operating income: -512617.7658142665
Net income: -687745.6258411844
Capital expenditures: 251527.59084791387
Operating cash flow: 243660.83445491252
Depreciation & amortization: 1050901.7496635262
Net tangible assets: 11206776.581426648
Owner earnings: 111628.53297442792
Buffett classification: The Gruesome
Stock price: 2.705248990578735
Shares outstanding: 6662259
Book value: 14919239.569313597
P/B ratio: 1.2080420956437057
Market cap (USD): 18023069.434724092
Debt to equity: 0.1290934276470129
Current ratio: 2.7526141826923074
Quick ratio: 2.7496670673076924
Interest coverage ratio: -48.27313054499367
COGS to revenue (%): 43.68913714532155
Free cash flow (dilution-adjusted): -587860.0269179004
Buyback yield (%): 0
Retained earnings: 4513977.119784657
Inventory turnover: 566.4212887438827
Receivables turnover: 8.97760802033324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.117643303134382
FCF margin (%): -2.747933214867327
Revenue growth (%): 12.062654107373682
Rule of 40 score: 9.314720892506354
Financial ratios for 9348.T — annual report dated 2024-03-31
Total revenue: 15564282.884310618
Gross profit: 6129444.004226096
Operating income: -36329206.28631801
Net income: -15625099.049128368
Capital expenditures: 13358042.789223455
Operating cash flow: -33178440.30639197
Depreciation & amortization: 550270.734284205
Net tangible assets: 63870985.2086635
Owner earnings: -28432871.104067616
Return on net tangible assets (%): -44.51609915077835
Buffett classification: The Gruesome
Stock price: 5.553354463814052
Shares outstanding: 146303888
Book value: 64350607.501320645
P/B ratio: 12.625791442318192
Market cap (USD): 812477349.4981511
Debt to equity: 1.2845471683863412
Current ratio: 2.074090834179652
Quick ratio: 2.0479305767300433
Interest coverage ratio: -14.950380030271985
COGS to revenue (%): 60.61848365863334
R&D to revenue (%): 162.67791799512528
SG&A to revenue (%): 67.81063657827247
Free cash flow (dilution-adjusted): -46777383.782356046
Buyback yield (%): 0.035256377229006625
Retained earnings: -32901234.812466983
Inventory turnover: 5.200025475852531
Receivables turnover: 117.3773716448384
Capitalized R&D asset: 80560151.87725742
ROCI (R&D-adjusted, %): -27.114798648714068
Rosenberg metric: 0.02855501341528038
FCF margin (%): -300.5431353956526
Revenue growth (%): 109.57102265172733
Rule of 40 score: -190.97211274392527
Financial ratios for 9348.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 36971928.84157445
Buffett classification: The Gruesome
Stock price: 4.909651211654293
Shares outstanding: 146303888
Book value: 37701701.9190363
P/B ratio: 19.052218452404936
Market cap (USD): 718301060.988934
Debt to equity: 3.359411367052388
Current ratio: 2.480612832676246
Quick ratio: 2.4399647448987962
Buyback yield (%): 0
Retained earnings: -79661976.46729234
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9348.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 46240495.92300495
Buffett classification: The Gruesome
Stock price: 5.046116829300895
Shares outstanding: 146303888
Book value: 46835890.9236733
P/B ratio: 15.762836936999417
Market cap (USD): 738266511.4289533
Debt to equity: 2.2969785886323764
Current ratio: 4.946403445785533
Quick ratio: 4.880024239204423
Buyback yield (%): 0
Retained earnings: -113137969.52279107
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9348.T — annual report dated 2025-03-31
Total revenue: 31701898.14195963
Gross profit: 15001550.594840262
Operating income: -65466795.88290335
Net income: -79836512.4983291
Capital expenditures: 16311315.332174843
Operating cash flow: -80536084.74802834
Depreciation & amortization: 1085175.7786392192
Net tangible assets: 46240495.92300495
Owner earnings: -95062652.05186473
Return on net tangible assets (%): -205.5831153068807
Buffett classification: The Gruesome
Stock price: 5.046116829300895
Shares outstanding: 146303888
Book value: 46835890.9236733
P/B ratio: 15.762836936999417
Market cap (USD): 738266511.4289533
Debt to equity: 2.2969785886323764
Current ratio: 4.946403445785533
Quick ratio: 4.880024239204423
Interest coverage ratio: -10.641780796617278
COGS to revenue (%): 52.67930894464921
R&D to revenue (%): 162.98990267829697
SG&A to revenue (%): 58.74628260272835
Free cash flow (dilution-adjusted): -100456075.39099051
Buyback yield (%): 0
Retained earnings: -113137969.52279107
Inventory turnover: 9.764914844891866
Receivables turnover: 3.070426601519665
Capitalized R&D asset: 91511387.70966688
ROCI (R&D-adjusted, %): -25.282799902245806
Rosenberg metric: 0.35040397946243834
FCF margin (%): -316.87716281578116
Revenue growth (%): 103.6836414346872
Rule of 40 score: -213.19352138109394
Financial ratios for 9348.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.9925269858843064
Shares outstanding: 146303888
Market cap (USD): 584122220.9797951
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9348.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 6953674.293405115
Buffett classification: The Gruesome
Stock price: 3.559892328398385
Shares outstanding: 146303888
Book value: 7427139.973082095
P/B ratio: 70.1247169696097
Market cap (USD): 520826088.50605655
Debt to equity: 27.967800245181337
Current ratio: 5.304928928753576
Quick ratio: 5.243178017097236
Buyback yield (%): 0
Retained earnings: -143951554.50874832
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9467.T — annual report dated 2022-03-31
Total revenue: 74497590.55892476
Gross profit: 57704589.411571875
Operating income: 17984215.702343877
Net income: 11389288.64120636
Capital expenditures: 68751.02442222586
Operating cash flow: 8798508.44123914
Depreciation & amortization: 213153.58138010162
Net tangible assets: 71569234.55171284
Owner earnings: 11533691.198164234
Return on net tangible assets (%): 16.115431819842208
Capex to operating income (%): 0.3822853637885669
Buffett classification: The Great
Stock price: 9.250040976889036
P/E ratio: 23.602619865469403
Shares outstanding: 29061174
Book value: 71950885.10080314
P/B ratio: 3.73611874210984
Market cap (USD): 268817050.33650225
Debt to equity: 0.004812375995891314
Current ratio: 5.960416437673361
Quick ratio: 5.755985909490873
Effective tax rate (%): 36.88198922509132
Interest coverage ratio: 9667.11013215859
COGS to revenue (%): 22.54167016860803
Free cash flow (dilution-adjusted): 8488206.851335848
Buyback yield (%): 0.0007133916559302972
Retained earnings: 57879331.25717096
Inventory turnover: 5.891637315085035
Receivables turnover: 3.446466235027247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.935880077820013
FCF margin (%): 11.393934740241027
Rule of 40 score: 11.393934740241027
Financial ratios for 9467.T — annual report dated 2023-03-31
Total revenue: 69734076.57657658
Gross profit: 52539054.05405406
Operating income: 18147605.105105106
Net income: 11308363.363363365
Capital expenditures: 36403.903903903905
Operating cash flow: 12153558.558558559
Depreciation & amortization: 207184.6846846847
Net tangible assets: 76966058.55855857
Owner earnings: 11479144.144144146
Return on net tangible assets (%): 14.914553712543817
Capex to operating income (%): 0.20059894235665904
Buffett classification: The Great
Stock price: 6.611336336336337
P/E ratio: 16.990362749154535
Shares outstanding: 29061174
Book value: 77220127.62762763
P/B ratio: 2.488123259382595
Market cap (USD): 192133195.64279282
Debt to equity: 0.006483940211872362
Current ratio: 5.733833029218702
Quick ratio: 5.517055854404132
Effective tax rate (%): 37.670320248412665
Interest coverage ratio: 12270.360406091371
COGS to revenue (%): 24.65799128155125
Free cash flow (dilution-adjusted): 12117154.654654656
Buyback yield (%): 0
Retained earnings: 64329654.65465466
Inventory turnover: 5.007503459855834
Receivables turnover: 3.31684974621682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.40934593485932
FCF margin (%): 17.37623160657836
Revenue growth (%): -6.394185297282105
Rule of 40 score: 10.982046309296257
Financial ratios for 9467.T — annual report dated 2024-03-31
Total revenue: 68238886.68779714
Gross profit: 50084039.88378236
Operating income: 15003836.502905441
Net income: 9266336.502905441
Capital expenditures: 422893.5552033809
Operating cash flow: 8241343.106180666
Depreciation & amortization: 185882.19756999472
Net tangible assets: 77039401.74326466
Owner earnings: 9029325.145272056
Return on net tangible assets (%): 11.720398836120847
Capex to operating income (%): 2.8185694713581353
Buffett classification: The Great
Stock price: 4.347926571579504
P/E ratio: 13.636009289785319
Shares outstanding: 29061174
Book value: 77185789.75171685
P/B ratio: 1.637035146525593
Market cap (USD): 126355850.63589542
Debt to equity: 0.004275894566317644
Current ratio: 5.975434324754251
Quick ratio: 5.720199468497767
Effective tax rate (%): 37.22123453564664
Interest coverage ratio: 10923.947115384615
COGS to revenue (%): 26.60483059139081
Free cash flow (dilution-adjusted): 7818449.550977285
Buyback yield (%): 0
Retained earnings: 65847893.55520338
Inventory turnover: 4.844557960378279
Receivables turnover: 3.4777199509341195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.382385800394218
FCF margin (%): 11.457469385085123
Revenue growth (%): -2.144130907272472
Rule of 40 score: 9.31333847781265
Financial ratios for 9467.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 88484997.89886539
Buffett classification: The Gruesome
Stock price: 5.202829527945091
Shares outstanding: 29061174
Book value: 88603705.00070037
P/B ratio: 1.7064786873500941
Market cap (USD): 151200334.20395014
Debt to equity: 0.00243786241179141
Current ratio: 5.795792793310421
Quick ratio: 5.543003512951633
Buyback yield (%): 0
Retained earnings: 76578134.19246393
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9467.T — annual report dated 2025-03-31
Total revenue: 91031860.71380831
Gross profit: 68213621.17363988
Operating income: 21535556.743750833
Net income: 13498081.80724502
Capital expenditures: 38591.09744686539
Operating cash flow: 13330036.091431627
Depreciation & amortization: 225223.90054805507
Net tangible assets: 91543396.60473199
Owner earnings: 13684714.610346211
Return on net tangible assets (%): 14.948882298342458
Capex to operating income (%): 0.17919711993544682
Buffett classification: The Great
Stock price: 9.286860045448469
P/E ratio: 19.994474737111574
Shares outstanding: 29061174
Book value: 91621781.8473466
P/B ratio: 2.9456647780992906
Market cap (USD): 269887055.6944259
Debt to equity: 0.005715233617569191
Current ratio: 5.121440847296003
Quick ratio: 4.912439954327484
Effective tax rate (%): 37.5965637652244
Interest coverage ratio: 7745.552884615384
COGS to revenue (%): 25.066205038154028
Free cash flow (dilution-adjusted): 13291444.99398476
Buyback yield (%): 0.0003665135283968321
Retained earnings: 80146958.96270552
Inventory turnover: 5.211428292304662
Receivables turnover: 3.612646582714015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.421373341553934
FCF margin (%): 14.600871485832023
Revenue growth (%): 33.401737824786544
Rule of 40 score: 48.00260931061857
Financial ratios for 9467.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 91543396.60473199
Buffett classification: The Gruesome
Stock price: 9.286860045448469
Shares outstanding: 29061174
Book value: 91621781.8473466
P/B ratio: 2.9456647780992906
Market cap (USD): 269887055.6944259
Debt to equity: 0.005715233617569191
Current ratio: 5.121440847296003
Quick ratio: 4.912439954327484
Buyback yield (%): 0
Retained earnings: 80146958.96270552
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9467.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.190907832825905
Shares outstanding: 29061174
Market cap (USD): 296159745.74771655
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9467.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 87516446.8371467
Buffett classification: The Gruesome
Stock price: 10.511170928667564
Shares outstanding: 29061174
Book value: 96441191.11709288
P/B ratio: 3.1673910676908865
Market cap (USD): 305466967.30174965
Debt to equity: 0.009233515693529645
Current ratio: 3.9866665794856098
Quick ratio: 3.740146046712113
Buyback yield (%): 0
Retained earnings: 84887967.69851951
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKEY.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.7613636363636362
Shares outstanding: 15902615
Market cap (USD): 59815517.78409091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKEY.PA — annual report dated 2022-12-31
Total revenue: 374348936.1702128
Gross profit: 31286170.21276596
Operating income: 15540425.531914895
Net income: 5463829.787234043
Capital expenditures: 239361.70212765958
Operating cash flow: 21128723.40425532
Depreciation & amortization: 12059574.468085106
Net tangible assets: -55907446.80851064
Owner earnings: 17284042.55319149
Return on net tangible assets (%): -30.915456776968014
Capex to operating income (%): 1.5402519167579407
Buffett classification: The Great
Stock price: 4.957446808510639
P/E ratio: 14.428774513239876
Shares outstanding: 15902615
Book value: 48975531.91489363
P/B ratio: 1.6097092751482502
Market cap (USD): 78836367.9787234
Debt to equity: 2.063253470034972
Current ratio: 1.0257675031061178
Quick ratio: 1.025656001444212
Effective tax rate (%): 40.60561838744984
Interest coverage ratio: 5.1220196353436185
COGS to revenue (%): 91.64251125358066
Free cash flow (dilution-adjusted): 17853191.489361703
Buyback yield (%): 0.19971342230419661
Retained earnings: 4072340.425531915
Inventory turnover: 15356.142857142857
Receivables turnover: 3.90799951134458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.805675947749453
FCF margin (%): 4.769131087164098
Rule of 40 score: 4.769131087164098
Financial ratios for ALKEY.PA — annual report dated 2023-12-31
Total revenue: 411487777.7777778
Gross profit: 34262222.222222224
Operating income: 18086666.666666668
Net income: 4165555.5555555555
Capital expenditures: 1934444.4444444445
Operating cash flow: 23855555.555555556
Depreciation & amortization: 10340000
Net tangible assets: -59101111.11111111
Owner earnings: 12571111.111111112
Return on net tangible assets (%): -21.270515688744336
Capex to operating income (%): 10.695417127411229
Buffett classification: The Great
Stock price: 7.511111111111111
P/E ratio: 28.67476057615364
Shares outstanding: 15902615
Book value: 53611111.111111104
P/B ratio: 2.228014039378239
Market cap (USD): 119446308.22222222
Debt to equity: 1.327958549222798
Current ratio: 1.010026236352865
Quick ratio: 1.0099698140886395
Effective tax rate (%): 38.75507835171212
Interest coverage ratio: 2.6874690440812286
COGS to revenue (%): 91.67357475178146
Free cash flow (dilution-adjusted): 21148888.88888889
Buyback yield (%): 0
Retained earnings: 3861111.111111111
Inventory turnover: 33950.299999999996
Receivables turnover: 4.209593634555271
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.893395893857805
FCF margin (%): 5.139615325418063
Revenue growth (%): 9.920915493313522
Rule of 40 score: 15.060530818731586
Financial ratios for ALKEY.PA — annual report dated 2024-12-31
Total revenue: 369361458.3333334
Gross profit: 25094791.666666668
Operating income: 11783333.333333334
Net income: 815625
Capital expenditures: 2907291.666666667
Operating cash flow: 17984375
Depreciation & amortization: 8929166.666666668
Net tangible assets: -46967708.333333336
Owner earnings: 6837500.000000001
Return on net tangible assets (%): -14.557874426134978
Capex to operating income (%): 24.672913719943423
Buffett classification: The Great
Stock price: 8.125
P/E ratio: 158.41685440613026
Shares outstanding: 15902615
Book value: 60335416.66666669
P/B ratio: 2.1415074928351916
Market cap (USD): 129208746.875
Debt to equity: 1.077621629087393
Current ratio: 0.9994343148066671
Quick ratio: 0.999400030855556
Effective tax rate (%): 132.53968253968256
Interest coverage ratio: 1.8076062639821031
COGS to revenue (%): 93.20589869340951
Free cash flow (dilution-adjusted): 13536458.333333334
Buyback yield (%): 0
Retained earnings: 815625
Inventory turnover: 55082.66666666667
Receivables turnover: 4.158939232221818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.112541891186659
FCF margin (%): 3.6648269677117318
Revenue growth (%): -10.237562746564628
Rule of 40 score: -6.572735778852896
Financial ratios for ALKEY.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -46967708.333333336
Buffett classification: The Gruesome
Stock price: 8.125
Shares outstanding: 15902615
Book value: 60335416.66666669
P/B ratio: 2.1415074928351916
Market cap (USD): 129208746.875
Debt to equity: 1.077621629087393
Current ratio: 0.9994343148066671
Quick ratio: 0.999400030855556
Buyback yield (%): 0
Retained earnings: 815625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKEY.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -41480000
Buffett classification: The Gruesome
Stock price: 9.388235294117647
Shares outstanding: 15902615
Book value: 75183529.41176468
P/B ratio: 1.9857739132475831
Market cap (USD): 149297491.4117647
Debt to equity: 1.6007260664100402
Current ratio: 1.0165466772398895
Quick ratio: 1.0165092130650066
Buyback yield (%): 0
Retained earnings: 13801176.470588235
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALRT.L — annual report dated 2021-09-30
Total revenue: 2570270.2702702703
Gross profit: 1485135.1351351351
Operating income: -11927027.027027028
Net income: -11913513.513513513
Capital expenditures: 44594.59459459459
Operating cash flow: -14440540.54054054
Depreciation & amortization: 39189.18918918919
Net tangible assets: 16248648.64864865
Owner earnings: -11918918.918918917
Return on net tangible assets (%): -73.35329341317363
Buffett classification: The Gruesome
Stock price: 0.0006756756756756757
Shares outstanding: 2473485974
Book value: 16316216.216216216
P/B ratio: 0.10243026229915522
Market cap (USD): 1671274.3067567567
Debt to equity: 0
Current ratio: 8.399136335595312
Quick ratio: 8.399136335595312
COGS to revenue (%): 42.218717139852785
SG&A to revenue (%): 384.12197686645635
Free cash flow (dilution-adjusted): -14613513.513513513
Buyback yield (%): 0
Retained earnings: -15550000
Receivables turnover: 1.95679012345679
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -73.09922146761637
FCF margin (%): -568.5594111461619
Rule of 40 score: -568.5594111461619
Financial ratios for ALRT.L — annual report dated 2022-09-30
Total revenue: 4947777.777777778
Gross profit: 3074444.4444444445
Operating income: -9528888.888888888
Net income: -9720000
Capital expenditures: 1800000
Operating cash flow: -5966666.666666667
Depreciation & amortization: 477777.77777777775
Net tangible assets: 3708888.888888889
Owner earnings: -11042222.222222222
Return on net tangible assets (%): -297.7231875374476
Buffett classification: The Gruesome
Stock price: 0.00022222222222222223
Shares outstanding: 2473485974
Book value: 3953333.333333332
P/B ratio: 0.13903799741427775
Market cap (USD): 549663.5497777777
Debt to equity: 0.9732996065205174
Current ratio: 1.3381365969206473
Quick ratio: 1.3381365969206473
Interest coverage ratio: -49.86046511627907
COGS to revenue (%): 37.86211542780148
SG&A to revenue (%): 155.44576689871997
Free cash flow (dilution-adjusted): -8253333.333333333
Buyback yield (%): 0
Retained earnings: -22505555.555555556
Receivables turnover: 3.238545454545455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -121.04446012702894
FCF margin (%): -166.80889288120366
Revenue growth (%): 92.50029209019746
Rule of 40 score: -74.3086007910062
Financial ratios for AZN — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1351351.3513513515
Buffett classification: The Gruesome
Stock price: 105.7
Shares outstanding: 1550876987
Market cap (USD): 163927697525.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZN — annual report dated 2022-12-31
Total revenue: 53434939759.03615
Gross profit: 38506024096.385544
Operating income: 5436144578.313253
Net income: 3967469879.5180726
Capital expenditures: 974698795.180723
Operating cash flow: 11816867469.879519
Depreciation & amortization: 6330120481.9277115
Net tangible assets: -26614457831.325302
Owner earnings: 9322891566.26506
Return on net tangible assets (%): -35.02942507922137
Capex to operating income (%): 17.92996453900709
Buffett classification: The Great
Stock price: 125.95
P/E ratio: 49.23363313255375
Shares outstanding: 1550876987
Book value: 44648192771.08435
P/B ratio: 4.374935342044888
Market cap (USD): 195332956512.65
Debt to equity: 0.7864158886070483
Current ratio: 0.8592781348647929
Quick ratio: 0.6805613661430799
Effective tax rate (%): -31.66733306677329
Interest coverage ratio: 3.392481203007519
COGS to revenue (%): 27.93849067664765
R&D to revenue (%): 22.01077766003021
SG&A to revenue (%): 40.549254808234316
Free cash flow (dilution-adjusted): 8719277108.433735
Buyback yield (%): 0
Retained earnings: -691566265.060241
Inventory turnover: 2.636944030644818
Receivables turnover: 6.149611758180809
Capitalized R&D asset: 11761445783.13253
ROCI (R&D-adjusted, %): 13.783269961977188
FCF margin (%): 16.31755766499064
Rule of 40 score: 16.31755766499064
Financial ratios for AZN — annual report dated 2023-12-31
Total revenue: 57988607594.93671
Gross profit: 47522784810.12658
Operating income: 11040506329.113924
Net income: 7545569620.253164
Capital expenditures: 1555696202.5316455
Operating cash flow: 13094936708.86076
Depreciation & amortization: 6245569620.253164
Net tangible assets: -24043037974.683544
Owner earnings: 12235443037.974684
Return on net tangible assets (%): -50.88975465936612
Capex to operating income (%): 14.090804861270351
Buffett classification: The Great
Stock price: 127.76
P/E ratio: 26.259123410284317
Shares outstanding: 1550876987
Book value: 49577215189.87341
P/B ratio: 3.9965948692413016
Market cap (USD): 198140043859.12
Debt to equity: 0.7252974518715213
Current ratio: 0.8203130115905967
Quick ratio: 0.6427214982646847
Effective tax rate (%): 13.596173358457744
Interest coverage ratio: 5.48898678414097
COGS to revenue (%): 18.048067058130144
R&D to revenue (%): 23.86981292702626
SG&A to revenue (%): 39.776472899521956
Free cash flow (dilution-adjusted): 8312658227.848101
Buyback yield (%): 0
Retained earnings: 1901265822.78481
Inventory turnover: 1.5243362831858407
Receivables turnover: 5.4491495182585945
Capitalized R&D asset: 21721940826.597527
ROCI (R&D-adjusted, %): 14.719867584606655
Rosenberg metric: 0.7666371022746424
FCF margin (%): 14.33498504725939
Revenue growth (%): 8.521891961393122
Rule of 40 score: 22.85687700865251
Financial ratios for AZN — annual report dated 2024-12-31
Total revenue: 67591250000
Gross profit: 54832500000
Operating income: 12813750000
Net income: 8801250000
Capital expenditures: 2336250000
Operating cash flow: 14826250000
Depreciation & amortization: 6331250000
Net tangible assets: -21770000000
Owner earnings: 12796250000
Return on net tangible assets (%): -58.77928341754708
Capex to operating income (%): 18.23236757389523
Buffett classification: The Great
Stock price: 126.98
P/E ratio: 22.375271672689678
Shares outstanding: 1550876987
Book value: 51088750000
P/B ratio: 3.854671719493235
Market cap (USD): 196930359809.26
Debt to equity: 0.7368060482983044
Current ratio: 0.9268283930237565
Quick ratio: 0.7370630876336755
Effective tax rate (%): 18.98515705902658
Interest coverage ratio: 6.094530321046373
COGS to revenue (%): 18.876333844987332
R&D to revenue (%): 25.119745529192016
SG&A to revenue (%): 37.40129084755793
Free cash flow (dilution-adjusted): 9093750000
Buyback yield (%): 0
Retained earnings: 3950000000
Inventory turnover: 1.9302193645990924
Receivables turnover: 6.513249819320646
Capitalized R&D asset: 30134014450.205887
ROCI (R&D-adjusted, %): 12.444435580986395
Rosenberg metric: 0.5280909922267949
FCF margin (%): 13.454034360956484
Revenue growth (%): 16.559532644997933
Rule of 40 score: 30.013567005954418
Financial ratios for AZN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 126.98
Shares outstanding: 1550876987
Market cap (USD): 196930359809.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZN — quarterly report dated 2025-03-31
Total revenue: 17646753246.753246
Gross profit: 14736363636.363636
Operating income: 4771428571.428572
Net income: 3793506493.5064936
Capital expenditures: 555844155.8441558
Operating cash flow: 4822077922.077922
Depreciation & amortization: 1667532467.5324676
Net tangible assets: -22910389610.38961
Owner earnings: 4905194805.194805
Return on net tangible assets (%): -21.410350887137916
Capex to operating income (%): 11.64942841589548
Buffett classification: The Great
Stock price: 144.48
P/E ratio: 14.766727529352549
Shares outstanding: 1550876987
Book value: 53416883116.88312
P/B ratio: 4.1947544298207
Market cap (USD): 224070707081.75998
Debt to equity: 0.7608373246456444
Current ratio: 0.897353153215009
Quick ratio: 0.6953551443578564
Effective tax rate (%): 14.138741916519695
Interest coverage ratio: 10.527220630372494
COGS to revenue (%): 16.492493376508683
R&D to revenue (%): 23.248454518692967
SG&A to revenue (%): 34.052104798351486
Free cash flow (dilution-adjusted): 3563636363.6363635
Buyback yield (%): 0
Retained earnings: 4368831168.831169
Inventory turnover: 0.3808633582596873
Receivables turnover: 1.0255094339622643
Capitalized R&D asset: 4102597402.5974026
ROCI (R&D-adjusted, %): 7.199531656764198
FCF margin (%): 20.19428907859876
Rule of 40 score: 20.19428907859876
Financial ratios for AZN — quarterly report dated 2025-06-30
Total revenue: 19804109589.041096
Gross profit: 16416438356.164385
Operating income: 4805479452.054794
Net income: 3356164383.561644
Capital expenditures: 890410958.9041096
Operating cash flow: 4638356164.383562
Depreciation & amortization: 1902739726.0273974
Net tangible assets: -19764383561.643837
Owner earnings: 4368493150.684932
Return on net tangible assets (%): -22.102855558635987
Capex to operating income (%): 18.529076396807298
Buffett classification: The Great
Stock price: 137.36
P/E ratio: 15.868446728780981
Shares outstanding: 1550876987
Book value: 61383561643.83562
P/B ratio: 3.4704480683341576
Market cap (USD): 213028462934.32
Debt to equity: 0.7328498103101987
Current ratio: 0.8629234255725191
Quick ratio: 0.6700858778625954
Effective tax rate (%): 21.714102974096576
Interest coverage ratio: 7.990888382687926
COGS to revenue (%): 17.105900255931385
R&D to revenue (%): 24.541744483641146
SG&A to revenue (%): 34.63374144013281
Free cash flow (dilution-adjusted): 2004109589.041096
Buyback yield (%): 0
Retained earnings: 9620547945.20548
Inventory turnover: 0.3824029689191279
Receivables turnover: 1.020398080180689
Capitalized R&D asset: 7609014232.343
ROCI (R&D-adjusted, %): 5.773331506653712
Rosenberg metric: 0.40951488896694416
FCF margin (%): 10.119665214083144
Revenue growth (%): 12.225230965275568
Rule of 40 score: 22.344896179358713
Financial ratios for AZN — quarterly report dated 2025-09-30
Total revenue: 20528378378.37838
Gross profit: 16743243243.243244
Operating income: 4841891891.8918915
Net income: 3425675675.675676
Capital expenditures: 927027027.027027
Operating cash flow: 6937837837.837838
Depreciation & amortization: 2093243243.2432432
Net tangible assets: -18272972972.972973
Owner earnings: 4591891891.8918915
Return on net tangible assets (%): -25.12941872504067
Capex to operating income (%): 19.145967066703882
Buffett classification: The Great
Stock price: 151.86
P/E ratio: 22.270303679524755
Shares outstanding: 1550876987
Book value: 62122972972.97296
P/B ratio: 3.7911285950252736
Market cap (USD): 235516179245.82
Debt to equity: 0.7098388114245938
Current ratio: 0.8791918717331296
Quick ratio: 0.6855875961707876
Effective tax rate (%): 21.8557336621455
Interest coverage ratio: 8.255760368663594
COGS to revenue (%): 18.43854914093871
R&D to revenue (%): 24.11296162201303
SG&A to revenue (%): 34.448028437890855
Free cash flow (dilution-adjusted): 4605405405.405405
Buyback yield (%): 0
Retained earnings: 11098648648.64865
Inventory turnover: 0.42484453207947825
Receivables turnover: 1.059492258334496
Capitalized R&D asset: 9560240704.500978
ROCI (R&D-adjusted, %): 4.360205298413741
Rosenberg metric: 0.06724001340686789
FCF margin (%): 22.43433612007109
Revenue growth (%): 3.657164115765493
Rule of 40 score: 26.091500235836584
Financial ratios for AZN — annual report dated 2025-12-31
Total revenue: 79377027027.02702
Gross profit: 65008108108.10811
Operating income: 18009459459.45946
Net income: 13828378378.378378
Capital expenditures: 3779729729.7297297
Operating cash flow: 19695945945.945946
Depreciation & amortization: 7418918918.918919
Net tangible assets: -14082432432.432432
Owner earnings: 17467567567.567566
Return on net tangible assets (%): -124.03800019192015
Capex to operating income (%): 20.987469047797703
Buffett classification: The Great
Stock price: 181.96
P/E ratio: 20.407134432751377
Shares outstanding: 1550876987
Book value: 65836486486.48648
P/B ratio: 4.286340168113977
Market cap (USD): 282197576554.52
Debt to equity: 0.59830866807611
Current ratio: 0.9381389424176112
Quick ratio: 0.7239768755919914
Effective tax rate (%): 17.489114658925978
Interest coverage ratio: 8.257125154894673
COGS to revenue (%): 18.102112736001637
R&D to revenue (%): 24.2292173853828
SG&A to revenue (%): 35.366621835577725
Free cash flow (dilution-adjusted): 11716216216.216217
Buyback yield (%): 0
Retained earnings: 14827027027.027027
Inventory turnover: 1.6216257434802501
Receivables turnover: 5.737911497509035
Capitalized R&D asset: 35175979742.55901
ROCI (R&D-adjusted, %): 13.894410543829103
Rosenberg metric: 0.5993143257370601
FCF margin (%): 14.760210422376957
Revenue growth (%): 17.43683838814495
Rule of 40 score: 32.197048810521906
Financial ratios for AZN — quarterly report dated 2025-12-31
Total revenue: 20950000000
Gross profit: 16736486486.486486
Operating income: 4024324324.3243246
Net income: 3147297297.2972975
Capital expenditures: 1395945945.945946
Operating cash flow: 3164864864.864865
Depreciation & amortization: 1713513513.5135136
Net tangible assets: -14082432432.432432
Owner earnings: 3464864864.8648653
Return on net tangible assets (%): -24.604164667498324
Capex to operating income (%): 34.68770987239758
Buffett classification: The Good
Stock price: 181.96
P/E ratio: 20.564373719695027
Shares outstanding: 1550876987
Book value: 65836486486.48648
P/B ratio: 4.286340168113977
Market cap (USD): 282197576554.52
Debt to equity: 0.6080174059401876
Current ratio: 0.9381389424176112
Quick ratio: 0.7239768755919914
Effective tax rate (%): 11.411182959300115
Interest coverage ratio: 6.152892561983472
COGS to revenue (%): 20.112236341353288
R&D to revenue (%): 24.91130748887312
SG&A to revenue (%): 36.41230729536219
Free cash flow (dilution-adjusted): 1425675675.6756756
Buyback yield (%): 0
Retained earnings: 14827027027.027027
Inventory turnover: 0.4755223425346958
Receivables turnover: 1.0214798708572181
Capitalized R&D asset: 10139309329.877823
ROCI (R&D-adjusted, %): 3.444146904980049
Rosenberg metric: -0.0013650013650015628
FCF margin (%): 6.805134490098691
Revenue growth (%): 2.0538476729642476
Rule of 40 score: 8.858982163062938
Financial ratios for BKT.AX — annual report dated 2021-06-30
Operating income: -2356854.887218045
Net income: -2143045.112781955
Capital expenditures: 4317.293233082706
Depreciation & amortization: 10655.63909774436
Net tangible assets: 24934622.556390975
Owner earnings: -2136706.7669172934
Return on net tangible assets (%): -8.569236458602962
Buffett classification: The Gruesome
Stock price: 0.10526315789473685
Shares outstanding: 2148233974
Book value: 24934622.55639098
P/B ratio: 9.068911770715406
Market cap (USD): 226129892.00000003
Debt to equity: 0
Current ratio: 24.42081934642643
Quick ratio: 24.42081934642643
Free cash flow (dilution-adjusted): -2151721.052631579
Buyback yield (%): 0.12505554547596565
Retained earnings: -32164301.503759395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.452137813146729
Rule of 40 score: 0
Financial ratios for BKT.AX — annual report dated 2022-06-30
Operating income: -4485386.8965517245
Net income: -4190961.379310345
Capital expenditures: 44014.48275862069
Depreciation & amortization: 33228.275862068964
Net tangible assets: 37943794.48275862
Owner earnings: -4201747.586206896
Return on net tangible assets (%): -11.073609383258017
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 2148233974
Book value: 37943794.48275862
P/B ratio: 5.466393039199796
Market cap (USD): 207415694.04137933
Debt to equity: 0.00975497297254658
Current ratio: 14.979516937704215
Quick ratio: 14.979516937704215
Free cash flow (dilution-adjusted): -7992951.0344827585
Buyback yield (%): 0.4562764500011447
Retained earnings: -33486400.689655174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.692256055264414
Rule of 40 score: 0
Financial ratios for BKT.AX — annual report dated 2023-06-30
Operating income: -6516166.225165563
Net income: -5995519.205298013
Capital expenditures: 460481.45695364237
Depreciation & amortization: 189201.9867549669
Net tangible assets: 38274037.74834437
Owner earnings: -6266798.675496688
Return on net tangible assets (%): -16.37349766100331
Buffett classification: The Gruesome
Stock price: 0.0728476821192053
Shares outstanding: 2148233974
Book value: 38075796.68874172
P/B ratio: 4.110061489584047
Market cap (USD): 156493865.65562913
Debt to equity: 0.01193760378936034
Current ratio: 4.025647144476232
Quick ratio: 4.025647144476232
Free cash flow (dilution-adjusted): -16930931.125827815
Buyback yield (%): 0.2475356743680963
Retained earnings: -37886828.47682119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.95733695690576
Rule of 40 score: 0
Financial ratios for BNZI — annual report dated 2021-12-31
Capital expenditures: 7063
Buffett classification: The Gruesome
Stock price: 97600
Shares outstanding: 3280551
Market cap (USD): 320181777600
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNZI — annual report dated 2022-12-31
Total revenue: 5332979
Gross profit: 3376015
Operating income: -5908824
Net income: -15468502
Capital expenditures: 10806
Operating cash flow: -5168175
Depreciation & amortization: 161606
Net tangible assets: -26285584
Owner earnings: -15317702
Buffett classification: The Gruesome
Stock price: 101200
Shares outstanding: 3280551
Book value: -24114058
Market cap (USD): 331991761200
Debt to equity: -0.5890723577093495
Current ratio: 0.048675232177854515
Quick ratio: 0.048675232177854515
Interest coverage ratio: -2.4826052796322826
COGS to revenue (%): 36.69551295814216
SG&A to revenue (%): 173.92251122683965
Free cash flow (dilution-adjusted): -5949317
Buyback yield (%): 0
Retained earnings: -32360062
Receivables turnover: 77.94929548643591
Capitalized R&D asset: 0
FCF margin (%): -111.55710532518503
Rule of 40 score: -111.55710532518503
Financial ratios for BNZI — annual report dated 2023-12-31
Total revenue: 4561300
Gross profit: 3116682
Operating income: -9795551
Net income: -14406262
Capital expenditures: 0
Operating cash flow: -1550781
Depreciation & amortization: 180405
Net tangible assets: -34047655
Owner earnings: -14225857
Buffett classification: The Gruesome
Stock price: 18800
Shares outstanding: 3280551
Book value: -31876129
Market cap (USD): 61674358800
Debt to equity: -0.514457040878458
Current ratio: 0.07926536848656962
Quick ratio: 0.07926536848656962
Interest coverage ratio: -1.7635425064551566
COGS to revenue (%): 31.671190230855238
SG&A to revenue (%): 282.92532830552693
Free cash flow (dilution-adjusted): -2796577
Buyback yield (%): 0
Retained earnings: -46766324
Receivables turnover: 43.42068939256918
Capitalized R&D asset: 0
FCF margin (%): -61.31096397956723
Revenue growth (%): -14.469942596811276
Rule of 40 score: -75.7809065763785
Financial ratios for BNZI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 994
Shares outstanding: 3280551
Market cap (USD): 3260867694
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNZI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 306
Shares outstanding: 3280551
Market cap (USD): 1003848606
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNZI — annual report dated 2024-12-31
Total revenue: 4527879
Gross profit: 3105337
Operating income: -13467744
Net income: -31095029
Capital expenditures: 0
Operating cash flow: -9575403
Depreciation & amortization: 161896
Net tangible assets: -25620130
Owner earnings: -30933133
Buffett classification: The Gruesome
Stock price: 306
Shares outstanding: 3280551
Book value: -2763802
Market cap (USD): 1003848606
Debt to equity: -4.52364641171835
Current ratio: 0.09439058847108657
Quick ratio: 0.09439058847108657
Interest coverage ratio: -4.419854806256832
COGS to revenue (%): 31.417403159404216
SG&A to revenue (%): 365.48905127544265
Free cash flow (dilution-adjusted): -10741083
Buyback yield (%): 0
Retained earnings: -78279713
Receivables turnover: 4.831690891571099
Capitalized R&D asset: 0
FCF margin (%): -237.22106973264965
Revenue growth (%): -0.7327077806765615
Rule of 40 score: -237.9537775133262
Financial ratios for BNZI — quarterly report dated 2025-03-31
Total revenue: 3379000
Gross profit: 2773000
Operating income: -4907000
Net income: -3644000
Capital expenditures: 0
Operating cash flow: -4974000
Depreciation & amortization: 253000
Net tangible assets: -27983038
Owner earnings: -3391000
Buffett classification: The Gruesome
Stock price: 224
Shares outstanding: 3280551
Book value: 2944870
P/B ratio: 249.53340011613417
Market cap (USD): 734843424
Debt to equity: 5.36701178659839
Current ratio: 0.09020974111482373
Quick ratio: 0.09020974111482373
Interest coverage ratio: -13.706703910614525
COGS to revenue (%): 17.934300088783665
SG&A to revenue (%): 219.97632435631843
Free cash flow (dilution-adjusted): -5311000
Buyback yield (%): 0
Retained earnings: -81923192
Receivables turnover: 3.285753598624632
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -111.29182203559932
FCF margin (%): -157.17667949097367
Rule of 40 score: -157.17667949097367
Financial ratios for BNZI — quarterly report dated 2025-06-30
Total revenue: 3262250
Gross profit: 2707735
Operating income: -4705614
Net income: -7793756
Capital expenditures: 0
Operating cash flow: -4048726
Depreciation & amortization: 305701
Net tangible assets: -27469169
Owner earnings: -7488055
Buffett classification: The Gruesome
Stock price: 117.8
Shares outstanding: 3280551
Book value: 3158379
P/B ratio: 122.35672406636442
Market cap (USD): 386448907.8
Debt to equity: 5.010357211721582
Current ratio: 0.1263351428517959
Quick ratio: 0.1263351428517959
Interest coverage ratio: -8.768676894523134
COGS to revenue (%): 16.99793087592919
SG&A to revenue (%): 218.03365775155186
Free cash flow (dilution-adjusted): -4804416
Buyback yield (%): 0
Retained earnings: -89716948
Receivables turnover: 3.5342110765517325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -106.17992588006145
FCF margin (%): -147.273078396812
Revenue growth (%): -3.455164249778041
Rule of 40 score: -150.72824264659005
Financial ratios for BNZI — quarterly report dated 2025-09-30
Total revenue: 2844508
Gross profit: 2325097
Operating income: -4430206
Net income: -5887591
Capital expenditures: 0
Operating cash flow: -4393705
Depreciation & amortization: 300354
Net tangible assets: -24883580
Owner earnings: -5587237
Buffett classification: The Gruesome
Stock price: 58.8
Shares outstanding: 3280551
Book value: 5440237
P/B ratio: 35.457352096976656
Market cap (USD): 192896398.79999998
Debt to equity: 2.65013233798454
Current ratio: 0.08683619909335484
Quick ratio: 0.08683619909335484
Interest coverage ratio: -11.245090971855582
COGS to revenue (%): 18.26013496885929
SG&A to revenue (%): 227.1350968251803
Free cash flow (dilution-adjusted): -5058114
Buyback yield (%): 0
Retained earnings: -95739807
Receivables turnover: 3.1016266456730004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -63.830376428984735
FCF margin (%): -177.8203471391186
Revenue growth (%): -12.8053337420492
Rule of 40 score: -190.6256808811678
Financial ratios for BNZI — annual report dated 2025-12-31
Total revenue: 12161419
Gross profit: 9972836
Operating income: -18464980
Net income: -22492075
Capital expenditures: 0
Operating cash flow: -15706619
Depreciation & amortization: 1167165
Net tangible assets: -21964111
Owner earnings: -21324910
Buffett classification: The Gruesome
Stock price: 19.32
Shares outstanding: 3280551
Book value: 8055001
P/B ratio: 7.868434196345848
Market cap (USD): 63380245.32
Debt to equity: 1.3193241068498935
Current ratio: 0.0631848824427904
Quick ratio: 0.0631848824427904
Interest coverage ratio: -7.7437761402528755
COGS to revenue (%): 17.9961154204127
SG&A to revenue (%): 224.37632483512
Free cash flow (dilution-adjusted): -18385850
Buyback yield (%): 0
Retained earnings: -100771787
Receivables turnover: 16.84253101517036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -199.39067267456124
FCF margin (%): -151.18178232326343
Revenue growth (%): 168.58975250884575
Rule of 40 score: 17.407970185582315
Financial ratios for BNZI — quarterly report dated 2025-12-31
Total revenue: 2810846
Gross profit: 2302188
Operating income: -4287197
Net income: -5031981
Capital expenditures: 0
Operating cash flow: -2290188
Depreciation & amortization: 308807
Net tangible assets: -21964111
Owner earnings: -4723174
Buffett classification: The Gruesome
Stock price: 19.32
Shares outstanding: 3280551
Book value: 8055001
P/B ratio: 7.868434196345848
Market cap (USD): 63380245.32
Debt to equity: 1.3193241068498935
Current ratio: 0.0631848824427904
Quick ratio: 0.0631848824427904
Interest coverage ratio: -3.9134435716861176
COGS to revenue (%): 18.12105679215439
SG&A to revenue (%): 223.44084307713766
Free cash flow (dilution-adjusted): -3212320
Buyback yield (%): 0
Retained earnings: -100771787
Receivables turnover: 3.8927826542172044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -46.29450417592442
FCF margin (%): -114.28303080282592
Revenue growth (%): -1.1834032458337258
Rule of 40 score: -115.46643404865965
Financial ratios for BOXL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1987.2
Shares outstanding: 667057
Market cap (USD): 1325575670.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOXL — annual report dated 2022-12-31
Total revenue: 221781000
Gross profit: 64868000
Operating income: 3049000
Net income: -3743000
Capital expenditures: 1106000
Operating cash flow: 1190000
Depreciation & amortization: 9129000
Net tangible assets: -25778000
Owner earnings: 4280000
Capex to operating income (%): 36.27418825844539
Buffett classification: The Good
Stock price: 447.84
Shares outstanding: 667057
Book value: 51893000
P/B ratio: 5.75674574374193
Market cap (USD): 298734806.88
Debt to equity: 0.9438267203669088
Current ratio: 2.2948736462093864
Quick ratio: 1.0940278494069107
Interest coverage ratio: 0.30726594779804495
COGS to revenue (%): 70.75132675928056
R&D to revenue (%): 1.1191220167642855
SG&A to revenue (%): 26.754771599009835
Free cash flow (dilution-adjusted): -3229000
Buyback yield (%): 0
Retained earnings: -65043000
Inventory turnover: 2.695590180550068
Receivables turnover: 7.152149375987617
Capitalized R&D asset: 2482000
ROCI (R&D-adjusted, %): 3.148329116522314
FCF margin (%): -1.4559407703996285
Rule of 40 score: -1.4559407703996285